Secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: International insights from the TECOS trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Circulation. 2017;136:1193-1203

Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED, TECOS Study Group

Consult publication

Secondary prevention of cardiovascular disease in patients with type 2 diabetes mellitus: International insights from the TECOS trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Circulation. 2017;136:1193-1203

Categories